Silexion Therapeutics
(NASDAQ) SLXNW
Silexion Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$11.91M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.01
Volume
10,350
Open
$0.01
Price
$0.01
Volume
10,350
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.03
52-Week Range
$0.01 - $0.15
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.01
Volume
10,350
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.03
52-Week Range
$0.01 - $0.15
SLXNW News
SLXNW: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silexion Therapeutics
SLXNW Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
10.35K
Short Interest
0.00%
Avg. Volume
90.95K
Financials (TTM)
Gross Profit
$14.00K
Operating Income
$11.63M
EBITDA
$11.62M
Operating Cash Flow
$10.82M
Capital Expenditure
$9.00K
Free Cash Flow
$10.83M
Cash & ST Invst.
$5.99M
Total Debt
$468.00K
Silexion Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$3.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
11
N/A
Net Income
$4.41M
-152.5%
EBITDA
$4.14M
+29.1%
Quarterly Fundamentals
Net Cash
$5.52M
+269.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$286.00K
-91.4%
Short Term Debt
$182.00K
-84.3%
Return on Assets
-1.65%
N/A
Return on Invested Capital
-2.61%
N/A
Free Cash Flow
$3.02M
-3.1%
Operating Cash Flow
$3.02M
-3.1%